Follow
Carmen de Mendoza Fernández
Carmen de Mendoza Fernández
Investigador IIS Puerta de Hierro- Segovia de Arana
Verified email at idiphim.org
Title
Cited by
Cited by
Year
Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management
AMJ Wensing, DA Van De Vijver, G Angarano, B Åsjö, C Balotta, E Boeri, ...
The Journal of infectious diseases 192 (6), 958-966, 2005
5572005
Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe
LM Hofstra, N Sauvageot, J Albert, I Alexiev, F Garcia, D Struck, ...
Clinical infectious diseases 62 (5), 655-663, 2016
1892016
Natural pregnancies in HIV-serodiscordant couples receiving successful antiretroviral therapy
P Barreiro, J del Romero, M Leal, V Hernando, R Asencio, C de Mendoza, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 43 (3), 324-326, 2006
1682006
Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach
D Paraskevis, O Pybus, G Magiorkinis, A Hatzakis, AMJ Wensing, ...
Retrovirology 6, 1-11, 2009
1552009
Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes
C Garrido, V Roulet, N Chueca, E Poveda, A Aguilera, K Skrabal, ...
Journal of clinical microbiology 46 (3), 887-891, 2008
1492008
Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1 …
P Swanson, C de Mendoza, Y Joshi, A Golden, RL Hodinka, V Soriano, ...
Journal of clinical microbiology 43 (8), 3860-3868, 2005
1372005
The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes
DA van de Vijver, AMJ Wensing, G Angarano, B Åsjö, C Balotta, E Boeri, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 41 (3), 352-360, 2006
1362006
Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania
A Johannessen, C Garrido, N Zahonero, L Sandvik, E Naman, SL Kivuyo, ...
Clinical Infectious Diseases 49 (6), 976-981, 2009
1242009
Main differences between the first and second waves of COVID-19 in Madrid, Spain
V Soriano, P Ganado-Pinilla, M Sanchez-Santos, F Gómez-Gallego, ...
International Journal of Infectious Diseases 105, 374-376, 2021
1192021
Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms: data from seroconverters in the CASCADE collaboration from 1987 to 2003
B Masquelier, K Bhaskaran, D Pillay, R Gifford, E Balestre, LB Jørgensen, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 40 (5), 505-511, 2005
1142005
Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients
JV Fernández-Montero, E Vispo, P Barreiro, R Sierra-Enguita, ...
Clinical infectious diseases 58 (11), 1549-1553, 2014
1052014
Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial
V Soriano, P García-Gasco, E Vispo, A Ruiz-Sancho, F Blanco, ...
Journal of Antimicrobial Chemotherapy 61 (1), 200-205, 2008
982008
Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades
T Doyle, DT Dunn, F Ceccherini-Silberstein, C De Mendoza, F Garcia, ...
Journal of Antimicrobial Chemotherapy 70 (11), 3080-3086, 2015
972015
Broad phenotypic cross-resistance to elvitegravir in HIV-infected patients failing on raltegravir-containing regimens
C Garrido, J Villacian, N Zahonero, T Pattery, F Garcia, F Gutierrez, ...
Antimicrobial agents and chemotherapy 56 (6), 2873-2878, 2012
942012
Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance
C de Mendoza, C Rodriguez, F García, JM Eiros, L Ruíz, E Caballero, ...
Journal of antimicrobial chemotherapy 59 (4), 698-704, 2007
942007
High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients
S Masciotra, C Garrido, AS Youngpairoj, A McNulty, N Zahonero, A Corral, ...
Aids 21 (18), 2503-2511, 2007
912007
New findings in HCV genotype distribution in selected West European, Russian and Israeli regions
V Kartashev, M Döring, L Nieto, E Coletta, R Kaiser, S Sierra, A Guerrero, ...
Journal of Clinical Virology 81, 82-89, 2016
882016
Correlation between human immunodeficiency virus type 1 (HIV-1) RNA measurements obtained with dried blood spots and those obtained with plasma by use of Nuclisens EasyQ HIV-1 …
C Garrido, N Zahonero, A Corral, M Arredondo, V Soriano, C de Mendoza
Journal of clinical microbiology 47 (4), 1031-1036, 2009
872009
Hepatitis C therapy with HCV NS5B polymerase inhibitors
V Soriano, E Vispo, C de Mendoza, P Labarga, JV Fernandez-Montero, ...
Expert opinion on pharmacotherapy 14 (9), 1161-1170, 2013
852013
Drug resistance in patients experiencing early virological failure under a triple combination including indinavir
O Gallego, C de Mendoza, MJ Pérez-Elías, JM Guardiola, J Pedreira, ...
Aids 15 (13), 1701-1706, 2001
832001
The system can't perform the operation now. Try again later.
Articles 1–20